Mutations in Multiple Domains of c-Myb Disrupt Interaction with CBP/p300 and Abrogate Myeloid Transforming Ability
Diwakar R. Pattabiraman(Whitehead Institute for Biomedical Research), Thomas J. Gonda(University of South Australia), Shunsuke Ishii(National Hospital Organization), Dennis H. Dowhan(The University of Queensland), Jane Sun(University of Toronto)
Cited by 34
Related Papers
A family of cytokine-inducible inhibitors of signalling
|Nature|1997|2.1k
MYB function in normal and cancer cells
|Nature reviews. Cancer|2008|627